FDA device center guidance priority lists targets COVID, digital health

The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) has published its FY2023 guidance priority lists. Much of the center’s focus in the current fiscal year is on transitioning COVID-19 devices and diagnostics from emergency use authorizations (EUAs) to traditional marketing authorizations and addressing issues around digital health.